Portfolio Alerts Watch List Cart

Healthcare

Refine Search


Product Compare (0)
M
Mono Pharmacare Ltd
Score 48/100• Risky
Mono Pharmacare Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health67/100
Valuation 80/100 · PB 1.1877
Technical Avoid
1M -16.667% 6M -17.485% 1Y -39.13%
Confidence100%
No promoter pledgeDecent revenue growth
Weak ROEHigh debt/equity
#256
View details ➜
M
Mercury Laboratories Ltd
Score 48/100• Risky
Mercury Laboratories Ltd shows potential but faces significant risks and inconsistencies in growth and profitability.
Company’s Health68/100
Valuation 60/100 · PB 2.0161
Technical Avoid
1M 2.754% 6M 12.36% 1Y -6.503%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#257
View details ➜
M
Magenta Lifecare Ltd
Score 48/100• Decent
Magenta Lifecare Ltd shows potential in a growing sector, but faces challenges in profitability and market sentiment.
Company’s Health62/100
Valuation 100/100 · PB 0.7822
Technical Avoid
1M 18.859% 6M -16.667% 1Y -50.884%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#258
View details ➜
L
Lyka Labs Ltd
Score 48/100• Risky
Lyka Labs Ltd presents several risks with inconsistent financial performance and valuation concerns, making it a risky investment at this time.
Company’s Health72/100
Valuation 40/100 · PB 3.2539
Technical Avoid
1M -4.516% 6M -8.064% 1Y -38.664%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#259
View details ➜
K
KMS Medisurgi Ltd
Score 48/100• Risky
KMS Medisurgi Ltd shows potential in a growing sector, but faces significant risks and inconsistencies in financial performance.
Company’s Health65/100
Valuation 20/100 · PB 5.1601
Technical Avoid
1M 0% 6M -0.315% 1Y 1.2%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#260
View details ➜
K
KK Shah Hospitals Limited
Score 48/100• Risky
KK Shah Hospitals Limited shows potential but is currently facing significant risks and challenges that may hinder growth and profitability.
Company’s Health75/100
Valuation 60/100 · PB 2.1273
Technical Avoid
1M 3.321% 6M 0.072% 1Y -9.046%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#261
View details ➜
K
Kaya Ltd
Score 48/100• Risky
Kaya Ltd presents significant risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
Company’s Health43/100
Valuation 100/100 · PB -5.011
Technical Momentum
1M 14.535% 6M 60.33% 1Y 5.118%
Confidence100%
No promoter pledgeHealthy profit margins
#262
View details ➜
K
Kashyap Tele-Medicines Ltd
Score 48/100• Risky
Kashyap Tele-Medicines Ltd faces significant challenges in growth and profitability, making it a risky investment at this time.
Company’s Health48/100
Valuation 20/100 · PB 84.3337
Technical Watch
1M 29.663% 6M 104.891% 1Y 343.529%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#263
View details ➜
H
Hemant Surgical Industries Ltd
Score 48/100• Decent
Hemant Surgical Industries Ltd shows potential in a growing sector but faces challenges in growth consistency and market sentiment.
Company’s Health95/100
Valuation 20/100 · PB 6.2282
Technical Avoid
1M -12.201% 6M 186.019% 1Y 97.287%
Confidence100%
Low leverage (D/E)No promoter pledge
Thin margins
#264
View details ➜
H
Hamps Bio Ltd
Score 48/100• Risky
Hamps Bio Ltd presents several risks with inconsistent growth and profitability metrics, alongside high valuation concerns.
Company’s Health81/100
Valuation 60/100 · PB 2.0473
Technical Avoid
1M -20.562% 6M -2.568% 1Y -61.281%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#265
View details ➜
H
Haleos Labs Ltd
Score 48/100• Risky
Haleos Labs Ltd shows potential in a growing sector, but faces significant risks and inconsistencies in financial performance.
Company’s Health70/100
Valuation 80/100 · PB 1.6147
Technical Avoid
1M -5.095% 6M -0.106% 1Y -30.545%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#266
View details ➜
G
Gian Life Care Ltd
Score 48/100• Risky
Gian Life Care Ltd shows potential in a growing sector, but faces significant challenges in growth consistency and profitability metrics.
Company’s Health37/100
Valuation 100/100 · PB 0.7136
Technical Avoid
1M -16.867% 6M -18.788% 1Y -34.695%
Confidence100%
Low leverage (D/E)Reasonable PB valuation
Weak ROEPromoter pledge present
#267
View details ➜
D
Desh Rakshak Aushdhalaya Ltd
Score 48/100• Risky
Desh Rakshak Aushdhalaya Ltd shows potential in a growing sector, but faces significant challenges in profitability and market sentiment, making it a risky investment.
Company’s Health62/100
Valuation 40/100 · PB 3.7676
Technical Avoid
1M -9.735% 6M 108.032% 1Y 457.651%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROEThin margins
#268
View details ➜
C
Cian Healthcare Ltd
Score 48/100• Decent
Cian Healthcare Ltd shows potential for growth but faces challenges in valuation and execution risks.
Company’s Health18/100
Valuation 100/100 · PB 0.2494
Technical Momentum
1M 40.547% 6M 81.703% 1Y 25.217%
Confidence100%
Reasonable PB valuation
Weak ROEPromoter pledge present
#269
View details ➜
B
Bliss GVS Pharma Ltd
Score 48/100• Decent
Bliss GVS Pharma Ltd shows potential but faces challenges in profitability and execution risks. Investors should proceed with caution.
Company’s Health61/100
Valuation 80/100 · PB 1.4652
Technical Avoid
1M 1.324% 6M 21.485% 1Y 19.227%
Confidence100%
Low leverage (D/E)No promoter pledge
Weak ROE
#270
View details ➜
Showing 256 to 270 of 301 (21 Pages)